<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20201129049526N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-12-07</date_registration>
      <primary_sponsor>application for fund was done and still awaiting approval</primary_sponsor>
      <public_title>A healthy diet and  premenstrual syndrome</public_title>
      <acronym></acronym>
      <scientific_title>Effects of healthy diet in reducing symptoms of premenstrual syndrome and improving quality of life among Omani Adolescents; a randomized controlled open label trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-02-01</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>70</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/52660</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Consecutive or random sampling using computer-generated random number table will be used for the recruitment stage, depending on the prevalence rate of PMS (i.e if the prevalence is high, random sampling will be applied, whereas consecutive sampling will be utilized if there is a limited number of adolescents with PMS). Cluster randomization of schools will be carried to minimize contamination anticipated from recruiting subjects from the same school. Therefore, the intervention and control groups will be derived from different schools.</study_design>
      <phase>3</phase>
      <hc_freetext>premenstrual syndrome.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group :Subjects in the intervention group will receive an individual face-to-face dietary consultation by a well-experienced dietician. She will educate the participants about the importance of healthy diet, evaluate the baseline dietary habits of each participant and give advice on how to modify them. The healthy diet advice is derived from the food-based dietary guidelines (FBDG) that were proposed for Omani adolescents  (24). FBDG for Omani adolescents includes a daily intake of the following: i) carbohydrates (330-450 g),  ii) protein (48-60 g),   iii) fibers (19-48 g),  iv) energy (2400 lcal),  v) calcium (600-960 mg),   vi) salt (&lt;5 gm/day) (24). Subjects will be specifically advised to limit extra salt, caffeine and sugar intake. Special weighted scoops will be provided to each participant in order to estimate the amount of specific food intake at certain meal (e.g. rice, pasta, etc.). Then, all the participants will be instructed to fill in an online application of their type and amount of food intake on a daily basis. The dietician will assess the compliance to healthy diet through the online application and give advice where necessary. A motivational phone consultation for each participant in the intervention group will be carried out by the principal and co-principal investigators once every two weeks throughout the study period. It will basically include motivating the participants to comply with the dietary advice given and find out any challenges that they may have encountered which may impede their adherence. Both groups (intervention and control group) will receive similar advice regarding physical exercise at baseline. Intervention 2: Control group: Subjects in the control group will not receive dietary advice at baseline. However, dietary counseling for each subject in the control group will be provided at the end of the study by the same dietician. Notably, both groups (intervention and control group) will receive similar advice regarding physical exercise at baseline.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All collected deidentified IPD from the study titled: Effects of healthy diet in reducing symptoms of premenstrual syndrome and improving quality of life among Omani Adolescents; a randomized controlled open label trial

When:
Starting 6 months after publication

To whom:
Academic institutions only

Conditions:
For Systematic Reviews and Metaanalysi

Where to obtain:
Dr.Zaleikha Al Belushi : albelushi11@hotmail.com

How to obtain:
Authorized researchers from academic institutions only can get in touch with Dr Zaleikha Al belushi at her above email address.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Zalekha Issa Ali Al Belushi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Khadraween road</address>
        <city>Shinas</city>
        <country1>Oman</country1>
        <zip>324</zip>
        <telephone>+968 26 724056</telephone>
        <email>albelushi11@hotmail.com</email>
        <affiliation>Ministry of health</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Ethics committee of center of studies and research in Ministry of health</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Khadraween road</address>
        <city>Shinas</city>
        <country1>Oman</country1>
        <zip>324</zip>
        <telephone>+968 26 724056</telephone>
        <email>albelushi11@hotmail.com</email>
        <affiliation>Ministry of health,Oman</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Oman</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Adolescents  who are at grade 10 or 11, aged 16 years to 19 years old, and have regular menstrual cycles will be included in the study</inclusion_criteria>
      <agemin>16 years</agemin>
      <agemax>19 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>known to have psychiatric disorders (such as depression, generalized anxiety disorder, post-traumatic stress disorder, psychotic disorders), diabetes, thyroid disease, oral contraceptive use, herbal remedy use for PMS symptoms, and those who have had dietary advice before for PMS symptoms.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>N94.3</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>premenstrual syndrome</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group :Subjects in the intervention group will receive an individual face-to-face dietary consultation by a well-experienced dietician. She will educate the participants about the importance of healthy diet, evaluate the baseline dietary habits of each participant and give advice on how to modify them. The healthy diet advice is derived from the food-based dietary guidelines (FBDG) that were proposed for Omani adolescents  (24). FBDG for Omani adolescents includes a daily intake of the following: i) carbohydrates (330-450 g),  ii) protein (48-60 g),   iii) fibers (19-48 g),  iv) energy (2400 lcal),  v) calcium (600-960 mg),   vi) salt (&lt;5 gm/day) (24). Subjects will be specifically advised to limit extra salt, caffeine and sugar intake. Special weighted scoops will be provided to each participant in order to estimate the amount of specific food intake at certain meal (e.g. rice, pasta, etc.). Then, all the participants will be instructed to fill in an online application of their type and amount of food intake on a daily basis. The dietician will assess the compliance to healthy diet through the online application and give advice where necessary. A motivational phone consultation for each participant in the intervention group will be carried out by the principal and co-principal investigators once every two weeks throughout the study period. It will basically include motivating the participants to comply with the dietary advice given and find out any challenges that they may have encountered which may impede their adherence. Both groups (intervention and control group) will receive similar advice regarding physical exercise at baseline.</i_keyword>
      <i_keyword>Control group: Subjects in the control group will not receive dietary advice at baseline. However, dietary counseling for each subject in the control group will be provided at the end of the study by the same dietician. Notably, both groups (intervention and control group) will receive similar advice regarding physical exercise at baseline.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The improvements in the severity of premenstrual symptoms. Timepoint: At baseline and 2 months after intervention. Method of measurement: Daily Record of Severity of Problem (Arabic version).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Improvements in quality of life. Timepoint: at baseline and at the end of 2 months of starting the intervention. Method of measurement: The medical outcome study short form-36 (SF-36) and Perceived stress scale PSS.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>application for fund was done and still awaiting approval</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-11-23</approval_date>
        <contact_name>Ethics Committee of Ministry of Health</contact_name>
        <contact_address>P.O.Box:393, Post code:100, Muscat, Oman Muscta Muscat Oman</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
